New Delhi: Lupin has announced the appointment of Dr Kushkumar Thakare as Manager, Medical Affairs, India Region Formulations, reinforcing the company's commitment to strengthening its medical and scientific leadership.Over the…
Jodhpur: A junior resident doctor at a government hospital in Jodhpur district of Rajasthan has been suspended after a video surfaced on social media allegedly showing him verbally abusing a…
Panaji: Goa Chief Minister Pramod Sawant has directed officials to expedite measures to enhance critical care capacity and strengthen healthcare delivery in government hospitals across the coastal state. During a…
New Delhi: According to the Ministry of Health and Family Welfare, India’s doctor-population ratio is currently estimated at 1:811, based on the combined availability of Allopathic and AYUSH practitioners. However,…
Pfizer reported that its ultra-long-acting, once-monthly GLP-1 injectable achieved up to 12.3% placebo-adjusted weight loss by week 28, with no weight-loss plateau, in adults with obesity or overweight without type…
Public Citizen contends that Novo Nordisk and Eli Lilly's obesity drugs are straining budgets so much that generics should be authorized.
New Delhi: The Indian Pharmaceutical Market (IPM) started calendar year 2026 with a robust uptick, delivering 10.21% month-on-month value growth and 1.82% unit growth in January, data from PharmaTrac MAT…
New Delhi: Aurobindo Pharma Limited recently informed that the United States Food and Drug Administration (USFDA) has completed an inspection at its Unit-VII manufacturing facility located at Jedcherla in Telangana.…
New Delhi: Mankind Pharma Limited has informed the stock exchanges that the Goods and Services Tax (GST) Department, Mumbai, carried out a search and inspection operation at Bharat Serums and…
New Delhi: OneSource Specialty Pharma Limited has received regulatory approval in Saudi Arabia to commercialise a generic version of Ozempic (semaglutide), marking a significant milestone for the company's expansion in…